Clinicopathological factors, such as age, estrogen receptor (ER) and/or progesterone receptor (PR) status, nuclear grade, and tumor size, were believed to be associated with risk of local recurrence (LR) and progression to invasive cancer in DCIS patients [4, 5]. This evidence concerns the gene PGR and neoplasm.